Max has 7 years’ experience working in pricing and market access consultancy, specializing in rare diseases and advanced therapies. Through his work at both the specific product and wider portfolio level, he has extensive experience in partnering with clients to ensure all recommendations translate into clear and actionable strategies.
Max holds an MRes in Molecular and Cellular Biosciences from Imperial College London.
